Mutation in PYCR2 gene and hypomyelinating leukodystrophy in children: a case report study

Seyed Ahmad Hosseini1, Mousa Ghelichi-Ghojogh2

  • 1Department of Pediatrics, Neonatal and Children's Health Research Center Research Center, Golestan University of Medical Science, Gorgan, Iran.

Insights

Hypomyelinating leukodystrophies are rare inherited brain disorders. A PYCR2 gene mutation caused hypomyelinating leukodystrophy type 10 in a young child, highlighting advances in genetic diagnosis.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Hypomyelinating leukodystrophies are inherited central nervous system disorders.
  • Characterized by a lack of myelin in the brain.
  • Represents a heterogeneous group of conditions.

Purpose of the Study:

  • To present a case of hypomyelinating leukodystrophy.
  • To identify the genetic cause of the disorder in a pediatric patient.
  • To emphasize the role of genetic testing in diagnosing rare neurological conditions.

Main Methods:

  • Whole exome sequencing was performed.
  • Genetic analysis identified a specific mutation.
  • Clinical presentation was correlated with genetic findings.

Main Results:

  • A nonsense homozygous mutation in the PYCR2 gene was identified.
  • This mutation is associated with hypomyelinating leukodystrophy type 10.
  • The patient presented with neurological symptoms at 6 months of age.

Conclusions:

  • Genetic testing, including whole exome sequencing, is crucial for diagnosing hypomyelinating leukodystrophies.
  • Advances in genetic technology improve diagnostic capabilities for complex neurological disorders.
  • Increased awareness and accessibility of genetic testing aid in early and accurate diagnosis, even in developing regions.